Sulopenem versus Amoxicillin/Clavulanate for the Treatment of Uncomplicated Urinary Tract Infection

20256 citationsJournal Article

Authors

Sailaja Puttagunta · Fulcrum Therapeutics (United States)

Steven I. Aronin · Fulcrum Therapeutics (United States)

Jayanti Gupta

Anita Das · West County Health Centers

Kalpana Gupta · Boston University

Michael W. Dunne · Fulcrum Therapeutics (United States)

Abstract

Sulopenem was noninferior to amoxicillin/clavulanate for the treatment of adult women with uncomplicated urinary tract infection, but was associated with more frequent mild adverse events. (Funded by Iterum Therapeutics; REASSURE ClinicalTrials.gov number, NCT05584657.).

Topics & Keywords

Urinary Tract Infections Management Pediatric Urology and Nephrology Studies Urinary Bladder and Prostate Research

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: NEJM Evidence

Volume 4, Issue 7, pp. EVIDoa2400414-EVIDoa2400414

DOI: 10.1056/evidoa2400414

Field-Weighted Citation Impact: 8.58